suizoulogo9

 

大津赤十字病院・外科

 

Home

 

膵がんについて

 一般向け

膵臓癌問答

膵がんについて

 --- 膵癌取扱い規約

 

膵がん関連出版物

 

 一般・医療従事者向け

膵がん治療方針

膵がん外科治療

膵頭十二指腸切除術

 

膵がん放射線治療と化学療法

膵がんの診断方法

外来診察の方法

リンク

 

膵内分泌腫瘍について

 一般向け

膵内分泌腫瘍

 一般・医療従事者向け

インスリノーマ

グルカゴノーマ

 

膵がん・膵臓疾患の研究

臨床研究と基礎研究

英文論文

専門医と研究スタッフ

 

その他

講義・講演会発表等

 

 

 

 

 

 

 

University_hospital

大津赤十字病院・外科

英文論文

 2000年〜20076月までに発表された膵がん(膵ガン,すいがん,膵癌膵臓がんすい臓がん膵臓癌,すいぞうがん,膵臓ガンすい臓癌すい臓ガン)を中心とする研究業績のうち,英文論文だけをリストしています.青文字はPubMedに直接リンクしています.

 

 

1.     Mori, T., Doi, R., Kida, A., Nagai, K., Kami, K., Ito, D., Toyoda, E., Kawaguchi, Y., Uemoto, S. Effect of the XIAP inhibitor embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J Surg Res. 142(2): 281-6, 2007.

2.     Ito, T., Tanaka, M., Sasano, H., Osamura, R.Y., Sasaki, I., Kimura, W., Takano, K., Obara, T., Ishibashi, M., Nakao, K., Doi, R., Shimatsu, A., Nishida, T., Komoto, I., Hirata, Y., Imamura, M., Kawabe, K., Nakamura, K., Neuroendocrine Tumor Workshop Japan. Preliminary results of Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol 42(6): 497-500, 2007.

3.     Lyshchik, A., Higashi, T., Hara, T., Nakamoto, Y., Fujimoto, K., Doi, R., Imamura, M., Saga, T., Togashi, K. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer. Cancer Invest. 25(3):154-162, 2007.

4.     Doi, R., Kami, K., Ito, D., Fujimoto, K., Kawaguchi, Y., Wada, M., Kogire, M., Hosotani, R., Imamura, M., Uemoto, S. Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg. 31(1):147-154, 2007.

5.     Fujikura, J., Hosoda, K., Noguchi, M., Ebihara, K., Masuzaki, H., Hirata, M., Fujimoto, K., Doi, R., Iwanishi, M., Nakao, K. A Case of Secretin-responsive Insulinoma with Low Serum C-peptide Levels. Endocr J. 54(1):113-21, 2007.

6.     Takahashi, M., Yoshimoto, T., Shimoda, M., Kono, T., Koizumi, M., Yazumi, S., Shimada, Y., Doi, R., Chiba, T., Kubo, H. Loss of Function of the Candidate Tumor Suppressor prox1 by RNA Mutationin Human Cancer Cells. Neoplasia 8(12):1003-10, 2006.

7.     Kiba, T, Nishimura., T, Matsumoto S., Hatano, E., Mori, A., Yasumi, S., Doi, R., Ikai, I., Kitano, T., Nishimura, T., Yoshikawa, K., Ishiguro, H., Yanagihara, K., Doi, E., Teramukai, S., Fukushima, M. Single-Agent Gemcitabine for Biliary Tract Cancers. Study Outcomes and Systematic Review of the Literature. Oncology 70(5):358-365, 2006.

8.     Koizumi, M., Nagai, K., Kida, A., Kami, K., Ito, D., Fujimoto, K., Kawaguchi, Y., Doi, R. Forced expression of PDX-1 induces insulin production in intestinal epithelia.  Surgery 140(2):273-80, 2006.

9.     Masui, T., Hosotani, R., Ito, D., Kami, K., Koizumi, M., Mori, T., Toyoda, E., Nakajima, S., Miyamoto, Y., Fujimoto, K., Doi, R. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.  Surgery 140(2):149-60, 2006.

10.   Hanaoka, H., Mukai, T., Tamamura, H., Mori, T., Ishino, S., Ogawa, K., Iida, Y., Doi, R., Fujii, N., Saji, H. Development of a (111)In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors. Nucl Med Biol. 33(4):489-94, 2006.

11.   Fukuda, A., Kawagguchi, Y., Furuyama, K., Kodama, S., Horiguchi, M., Kuhara, T., Koizumi, M., Boyer, D.F., Fujimoto, K., Doi, R., Kageyama, R., Wright, C.V.E., Chiba, T. Ectopic pancreas formation in Hes1-knockout mice reveals plasticity of the endodermal gut, bile duct, and pancreas. J Clin Invest. e-pub

12.   Tomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., Fujimoto, K., Doi, R., Shimada, Y., Hosoda, K., Imamura, M., Nakao, K. Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion. Diabetologia. 49(5):962-8, 2006.

13.   Fukuda, A., Kawaguchi, Y., Furuyama, K., Kodama, S., Kuhara, T., Horiguchi, M., Koizumi, M., Fujimoto, K., Doi, R., Wright, C.V.E., Chiba, T. Loss of major duodenal papilla results in brown pigment biliary stone formation in pdx1 null mice. Gastroenterology 130(3):  855-867, 2006.

14.   Tulachan, S.S., Doi, R., Hirai, Y., Kawaguchi, Y., Koizumi, M., Hembree, M., Tei, E., Crowley, A., Yew, H., McFall, C., Prasadan, K., Preuett, B., Imamura, M., Gittes, G.K. Mesenchymal epimorphin is important for pancreatic duct morphogenesis. Dev Growth Differ. 48(2):65-72, 2006.

15.   Ito, D., Fujimoto, K., Mori, T., Kami, K., Koizumi, M., Toyoda, E., Doi, R. In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. Int J Cancer 118(9): 2337-2343, 2006.

16.   Furuyama, K., Doi, R., Mori, T., Toyoda, E., Ito, D., Kami, K., Koizumi, M., Kida, A., Kawaguchi, Y., Fujimoto, K. Focal adhesion kinase is not a prognostic factor in pancreatic cancer patients. World J Surg 30(2):219-26, 2006.

17.   Oya, N., Shibuya, K., Sakamoto, T., Mizowaki, T., Doi, R., Fujimoto, K., Imamura, M., Nagata, Y., Hiraoka, M. Chemoradiotherapy in Patients with Pancreatic Carcinoma: Phase-I Study with a Fixed Radiation Dose and Escalating Doses of Weekly Gemcitabine. Pancreatology 6(1-2): 109-116, 2005.

18.   Tomita, T., Masuzaki, H., Noguchi, M., Iwakura, H., Fujikura, J., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., Fujimoto, K., Doi, R., Shimada, Y., Hosoda, K., Imamura, M., Nakao, K. GPR40 gene expression in human pancreas and insulinoma. Biochem Biophys Res Commun. 338: 1788-1790, 2005.

19.   Terada, T., Shimada, Y., Pan, X., Kishimoto, K., Sakurai, T., Doi, R., Onodera, H., Katsura, T., Imamura, M., Inui, K.: Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract.  Biochem Pharmacol Biochemical Pharmacology 70(12): 1756-1763, 2005.

20.   Doi, R., Fujimoto, K., Kobayashi, H., Imamura, M. Impact of Reconstruction Methods on Outcome of Pancreatoduodenectomy in Pancreatic Cancer Patients. World J Surg 29(4): 500-504, 2005.

21.   Mori, T., Doi, R., Toyoda, E., Koizumi, K., Ito, D., Kami, K., Kida, A., Masui, T., Kawaguchi, Y., Fujimoto, K. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy to pancreatic cancer. Surgery 138: 71-77, 2005.

22.   Kami, K., Doi, R., Koizumi, M., Toyoda, E., Mori, T., Ito, D., Kawaguchi, Y., Fujimoto, K., Wada, M., Miyatake, S., Imamura, M. Down-regulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 138(2): 299-305, 2005.

23.   Koizumi, M., Doi, R., Fujimoto, K., Ito, D., Toyoda, E., Mori, T., Kami, K., Kawaguchi, Y., Gittes, G.K., Imamura M. Pancreatic epithelial cells can be converted into insulin-producing cells by GLP-1 in conjunction with virus-mediated gene transfer of pdx-1. Surgery 138(2): 125-133, 2005.

24.   Kataoka, K., Fujimoto, K., Ito, D., Koizumi, M., Toyoda, E., Mori, T., Kami, K., Doi, R. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer. Surgery 138(3): 450-455, 2005.

25.   Saga, T., Shimatsu, A., Koizumi, K., Ichikawa, T., Yamamoto, K., Noguchi, S., Doi, R., Ishibashi, M., Machinami, R., Nakamura, K., Sakahara, H., Endo, K. Morphological imaging in the localization of neuroendocrine gastroenteropancreatic tumors found by somatostatin receptor scintigraphy. Acta Radiol 46: 227-232, 2005.

26.   Kawamura, J., Shimada, Y., Komoto, I., Okamoto, H., Itami, A., Doi, R., Fujimoto, K., Kosugi, S., Imamura, M. Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan. Oncol Rep 14: 47-52, 2005.

27.   Imamura, M., Komoto, I., Doi, R., Onodera, H., Kobayashi, H., Kawai, Y. New Pancreas-preserving Total Duodenectomy Technique. World J Surg 29: 203-207, 2005.

28.   Toyoda, E., Doi, R., Koizumi, M., Kami, K., Ito, D., Mori, T., Fujimoto, K., Nakajima, S., Wada, M., Imamura, M. Analysis of E-, N-cadherin, alpha-, beta-, and gamma-catenin expression in human pancreatic carcinoma cell lines. Pancreas 30: 168-173, 2005.

29.   Koizumi, M., Doi, R., Toyoda, E., Tulachan, S.S., Kami, K., Mori, T., Ito, D., Kawaguchi, Y., Fujimoto, K., Gittes, G.K., Imamura, M. Hepatic regeneration and enforced PDX-1 expression accelerate transdifferentiation in liver. Surgery 136: 449-457, 2004.

30.   Kami, K., Doi, R., Koizumi, M., Toyoda, E., Mori, T., Ito, D., Fujimoto, K., Wada, M., Miyatake, S., Imamura, M. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery 136: 443-448, 2004.

 

 

 

31.   Ito, D., Fujimoto, K., Doi, R., Koizumi, M., Toyoda, E., Mori, T., Kami, K., Kawaguchi, Y., Whitehead, R., Imamura, M. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells. Surgery 136: 364-374, 2004.

32.   Imamura, M., Doi, R., Imaizumi, T., Funakoshi, A., Wakasugi, H., Sunamura, M., Ogata, Y., Hishinuma, S., Asano, T., Aikou, T., Hosotani, R., Maetani, S. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 136: 1003-1011, 2004.

33.   Hosotani, R., Ida, J., Kogire, M., Fujimoto, K., Doi, R., Imamura, M. Expression of pancreatic duodenal hoemobox-1 in pancreatic islet neogenesis after surgical wrapping in rats. Surgery 135: 297-306, 2004.

34.   Imamura, M., Doi, R. Treatment of locally advanced pancreatic cancer: should we resect when resectable? Pancreas 28: 293-295, 2004.

35.   Doi, R., Komoto, I., Nakamura, Y., Kawamura, J., Fujimoto, K., Wada, M., Saga, T., Imamura, M. Pancreatic endocrine tumor in Japan. Pancreas 28: 247-252, 2004.

36.   Mori, T., Doi, R., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Masui, T., Fujimoto, K., Tamamura, H., Hiramatsu, K., Fujii, N., Imamura, M. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3: 29-37, 2004.

37.   Doi, R., Fujimoto, K., Imamura, M. Effects of preceding gastrectomy on the outcome of pancreatoduodenectomy. J Gastrointest Surg 8: 575-579, 2004.

38.   Onoue, M., Terada, T., Okuda, M., Fujimoto, K., Doi, R., Imamura, M., Inui, K. Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer. Int J Clin Oncol 9: 174-178, 2004.

39.   Lyshchik, A., Higashi, T., Nakamoto, Y., Fujimoto, K., Doi, R., Imamura, M., Saga, T. Dual-phase (18)F-fluoro-2-deoxy- d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging 32: 389-397, 2005.

40.   Nakajima, S., Doi, R., Toyoda, E., Tsuji, S., Wada, M., Koizumi, M., Tulachan, S.S., Ito, D., Kami, K., Mori, T., Kawaguchi, Y., Fujimoto, K., Hosotani, R., Imamura, M. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10: 4125-4133, 2004.

41.   Masui, T., Doi, R., Mori, T., Toyoda, E., Koizumi, M., Kami, K., Ito, D., Peiper, S.C., Broach, J.R., Oishi, S., Niida, A., Fujii, N., Imamura, M. Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315: 85-92, 2004.

42.   Koizumi, M., Ito, D., Fujimoto, K., Toyoda, E., Kami, K., Mori, T., Doi, R., Whitehead, R., Imamura, M. Conditional transformation of mouse pancreatic epithelial cells: an in vitro model for analysis of genetic events in pancreatocarcinogenesis. Biochem Biophys Res Commun 319: 612-621, 2004.

43.   Koizumi, M., Doi, R., Toyoda, E., Masui, T., Tulachan, S.S., Kawaguchi, Y., Fujimoto, K., Gittes, G.K., Imamura, M. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery 134: 260-266, 2003.

44.   Doi, R., Ito, D., Fujimoto, K., Komoto, I., Ohta, Y., Torii, M., Imamura, M. Hand-assisted laparoscopic resection of serous cystadenoma of the pancreas. Surg Endosc 17: 2028-2031, 2003.

45.   Komoto, I., Kato, M., Itami, A., Shimada, Y., Doi, R., Hosotani, R., Imamura, M. Expression and function of the calcium-sensing receptor in pancreatic islets and insulinoma cells. Pancreas 26: 178-184, 2003.

46.   Ogawa, M., Hatano, K., Oishi, S., Kawasumi, Y., Fujii, N., Kawaguchi, M., Doi, R., Imamura, M., Yamamoto, M., Ajito, K., Mukai, T., Saji, H., Ito, K. Direct electrophilic radiofluorination of a cyclic RGD peptide for in vivo alpha(v)beta3 integrin related tumor imaging. Nucl Med Biol 30: 1-9, 2003.

47.   Tsuji, S., Hosotani, R., Yonehara, S., Masui, T., Tulachan, S.S., Nakajima, S., Kobayashi, H., Koizumi, M., Toyoda, E., Ito, D., Kami, K., Mori, T., Fujimoto, K., Doi, R., Imamura, M. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 106: 17-25, 2003.

48.   Doi, R., Ikeda, H., Kobayashi, H., Kogire, M., Imamura, M. Carcinoma in the remnant pancreas after distal pancreatectomy for carcinoma. Eur J Surg 168: S62-65, 2003.

49.   Tulachan, S.S., Doi, R., Kawaguchi, Y., Tsuji, S., Nakajima, S., Masui, T., Koizumi, M., Toyoda, E., Mori, T., Ito, D., Kami, K., Fujimoto, K., Imamura, M. All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes 52: 76-84, 2003.

50.   Masui, T., Doi, R., Koshiba, T., Fujimoto, K., Tsuji, S., Nakajima, S., Koizumi, M., Toyoda, E., Tulachan, S., Ito, D., Kami, K., Mori, T., Wada, M., Noda, M., Imamura, M. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin Cancer Res 9: 1779-1784, 2003.

51.   Higashi, T., Saga, T., Nakamoto, Y., Ishimori, T., Fujimoto, K., Doi, R., Imamura, M., Konishi, J. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality". Ann Nucl Med 17: 261-279, 2003.

52.   Wada, M., Komoto, I., Doi, R., Imamura, M. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J Surg 26: 1291-1296, 2002.

53.   Hosotani, R., Doi, R., Imamura, M. Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy. World J Surg 26: 99-104, 2002.

54.   Doi, R., Fujimoto, K., Wada, M., Imamura, M. Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 132: 80-85, 2002.

55.   Shibamoto, Y., Oya, N., Kokubo, M., Hiraoka, M., Doi, R., Tsujitani, M. (2002). Intraoperative radiotherapy using hypoxic cell sensitizer: Japanese clinical trial. Progress in Radio-Oncology VII. H. D. Kogelnik, P. Lukas and F. Sedlmayer. Bologna, Monduzzi Editore: 333-339.

56.   Hosotani, R., Kawaguchi, M., Masui, T., Koshiba, T., Ida, J., Fujimoto, K., Wada, M., Doi, R., Imamura, M. Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis. Pancreas 25: e30-35, 2002.

57.   Higashi, T., Saga, T., Nakamoto, Y., Ishimori, T., Mamede, M.H., Wada, M., Doi, R., Hosotani, R., Imamura, M., Konishi, J. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43: 173-180, 2002.

58.   Iwakura, H., Hosoda, K., Doi, R., Komoto, I., Nishimura, H., Son, C., Fujikura, J., Tomita, T., Takaya, K., Ogawa, Y., Hayashi, T., Inoue, G., Akamizu, T., Hosoda, H., Kojima, M., Kangawa, K., Imamura, M., Nakao, K. Ghrelin expression in islet cell tumors: augmented expression of ghrelin in a case of glucagonoma with multiple endocrine neoplasm type I. J Clin Endocrinol Metab 87: 4885-4888, 2002.

59.   Lee, J.U., Hosotani, R., Wada, M., Doi, R., Koshiba, T., Fujimoto, K., Miyamoto, Y., Tsuji, S., Nakajima, S., Hirohashi, M., Uehara, T., Arano, Y., Fujii, N., Imamura, M. Antiproliferative activity induced by the somatostatin analogue, TT-232, in human pancreatic cancer cells. Eur J Cancer 38: 1526-1534, 2002.

60.   Nakamura, Y., Doi, R., Kohno, Y., Shimono, D., Kuwamura, N., Inoue, K., Koshiyama, H., Imamura, M. High-dose calcium stimulation test in a case of insulinoma masquerading as hysteria. Endocrine 19: 127-130, 2002.

61.   Hosotani, R., Miyamoto, Y., Fujimoto, K., Doi, R., Otaka, A., Fujii, N., Imamura, M. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice. Clin Cancer Res 8: 1271-1276, 2002.

62.   Masui, T., Hosotani, R., Doi, R., Miyamoto, Y., Tsuji, S., Nakajima, S., Kobayashi, H., Koizumi, M., Toyoda, E., Tulachan, S.S., Imamura, M. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Anticancer Res 22: 4093-4100, 2002.

63.   Itami, A., Kato, M., Komoto, I., Doi, R., Hosotani, R., Shimada, Y., Imamura, M. Human gastrinoma cells express calcium-sensing receptor. Life Sci 70: 119-129, 2001.

64.   Masui, T., Hosotani, R., Tsuji, S., Miyamoto, Y., Yasuda, S., Ida, J., Nakajima, S., Kawaguchi, M., Kobayashi, H., Koizumi, M., Toyoda, E., Tulachan, S., Arii, S., Doi, R., Imamura, M. Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 7: 3437-3443, 2001.

65.   Kawaguchi, M., Hosotani, R., Ohishi, S., Fujii, N., Tulachan, S.S., Koizumi, M., Toyoda, E., Masui, T., Nakajima, S., Tsuji, S., Ida, J., Fujimoto, K., Wada, M., Doi, R., Imamura, M. A novel synthetic Arg-Gly-Asp-containing peptide cyclo(-RGDf==V-) is the potent inhibitor of angiogenesis. Biochem Biophys Res Commun 288: 711-717, 2001.

66.   Miyamoto, Y., Hosotani, R., Doi, R., Wada, M., Ida, J., Tsuji, S., Kawaguchi, M., Nakajima, S., Kobayashi, H., Masui, T., Imamura, M. Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. Anticancer Res 21: 2449-2456, 2001.

67.   Kato, M., Imamura, M., Hosotani, R., Shimada, Y., Doi, R., Itami, A., Komoto, I., Kosaka, M.T.T., Konishi, J. Curative resection of microgastrinomas based on the intraoperative secretin test. World J Surg 24: 1425-1430, 2000.

68.   Kogire, M., Hosotani, R., Kondo, M., Itoh, K., Doi, R., Terachi, T., Imamura, M. Pancreatic lesions in von Hippel-Lindau syndrome: the coexistence of metastatic tumors from renal cell carcinoma and multiple cysts. Surg Today 30: 380-382, 2000.

69.   Kobayashi, H., Doi, R., Hosotani, R., Miyamoto, Y., Koshiba, T., Fujimoto, K., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Shiota, K., Imamura, M. Immunohistochemical analysis of apoptosis-related proteins in human embryonic and fetal pancreatic tissues. Int J Pancreatol 27: 113-122, 2000.

70.   Kawaguchi, M., Hosotani, R., Kogire, M., Ida, J., Doi, R., Koshiba, T., Miyamoto, Y., Tsuji, S., Nakajima, S., Kobayashi, H., Masui, T., Imamura, M. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Int J Oncol 16: 37-41, 2000.

71.   Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., Fujii, N., Imamura, M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6: 3530-3535, 2000.

72.   Fujimoto, K., Hosotani, R., Miyamoto, Y., Doi, R., Koshiba, T., Otaka, A., Fujii, N., Beauchamp, R.D., Imamura, M. Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells. Cancer Lett 159: 151-158, 2000.

73.   Nakamoto, Y., Higashi, T., Sakahara, H., Tamaki, N., Kogire, M., Doi, R., Hosotani, R., Imamura, M., Konishi, J. Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 89: 2547-2554, 2000.

 

検索用語:膵腫瘍,膵がん,膵ガン,すいがん,膵癌膵臓がんすい臓がん膵臓癌,すいぞうがん,膵臓ガンすい臓癌すい臓ガン膵内分泌腫瘍,腫瘤形成性膵炎,慢性膵炎,インスリノーマ,グルカゴノーマ,合流異常,IPMN/IPMTMCN/MCT,膵嚢胞,膵頭十二指腸切除術(PD/PPPD),膵体尾部切除術(DP),幽門輪温存手術

 

膵がん/大津赤十字病院・外科ホーム

 

このページに関するお問い合わせ先

このサイトはリンクフリーです

 

Revised on 2010-03-15.

Copyright: 2010 Department of Surgery, ORCH. All rights reserved.